Table 4.
Correlations | ||||||||
---|---|---|---|---|---|---|---|---|
NPFV | AFA | SFT | PSA | BMI | Biopsy GS | Post-op GS | ||
Age | Pearson C. | 0.154 | 0.046 | −0.090 | 0.061 | −0.149 | 0.133 | 0.147 |
Sig. (2-tailed) | 0.050 | 0.561 | 0.256 | 0.444 | 0.064 | 0.092 | 0.062 | |
N | 162 | 162 | 162 | 162 | 156 | 162 | 162 | |
NPFV | Pearson C. | 1 | 0.129 | 0.042 | 0.036 | 0.117 | 0.331** | 0.294** |
Sig. (2-tailed) | 0.101 | 0.596 | 0.645 | 0.146 | 0.000 | 0.000 | ||
N | 162 | 162 | 162 | 162 | 156 | 162 | 162 | |
AFA | Pearson C. | 0.129 | 1 | 0.644** | 0.207** | 0.640** | 0.098 | 0.046 |
Sig. (2-tailed) | 0.101 | 0.000 | 0.008 | 0.000 | 0.213 | 0.563 | ||
N | 162 | 162 | 162 | 162 | 156 | 162 | 162 | |
SFT | Pearson C. | 0.042 | 0.644** | 1 | 0.162* | 0.794** | 0.062 | −0.004 |
Sig. (2-tailed) | 0.596 | 0.000 | 0.039 | 0.000 | 0.435 | 0.960 | ||
N | 162 | 162 | 162 | 162 | 156 | 162 | 162 | |
PSA | Pearson C. | 0.036 | 0.207** | 0.162* | 1 | 0.121 | 0.169* | 0.326** |
Sig. (2-tailed) | 0.645 | 0.008 | 0.039 | 0.132 | 0.031 | 0.000 | ||
N | 162 | 162 | 162 | 162 | 156 | 162 | 162 | |
BMI | Pearson C. | 0.117 | 0.640** | 0.794** | 0.121 | 1 | 0.079 | 0.020 |
Sig. (2-tailed) | 0.146 | 0.000 | 0.000 | 0.132 | 0.326 | 0.800 | ||
N | 156 | 156 | 156 | 156 | 156 | 156 | 156 |
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
NPFV = Normalised periprostatic fat volume; AFA = Abdominal fat area; SFT = Subcutaneous fat thickness; PSA = Prostate specific antigen; BMI = Body mass index; GS = Gleason score.